BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 174 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2019. The put-call ratio across all filers is 0.44 and the average weighting 1.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $9,673,670,000 | -80.4% | 63,992 | -81.1% | 0.01% | -80.8% |
| Q2 2022 | $49,354,016,000 | +586.7% | 338,714 | +458.8% | 0.03% | +766.7% |
| Q1 2022 | $7,187,239,000 | -7.5% | 60,616 | +7.5% | 0.00% | 0.0% |
| Q4 2021 | $7,769,314,000 | +1.8% | 56,377 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $7,628,521,000 | +44.6% | 54,917 | +1.0% | 0.00% | +50.0% |
| Q2 2021 | $5,276,687,000 | +48.2% | 54,354 | +4.3% | 0.00% | 0.0% |
| Q1 2021 | $3,561,708,000 | -16.2% | 52,103 | +5.1% | 0.00% | 0.0% |
| Q4 2020 | $4,249,930,000 | +45.4% | 49,585 | +10.3% | 0.00% | 0.0% |
| Q3 2020 | $2,922,720,000 | -10.5% | 44,958 | +0.6% | 0.00% | 0.0% |
| Q2 2020 | $3,266,189,000 | +87.8% | 44,675 | -12.6% | 0.00% | +100.0% |
| Q1 2020 | $1,739,615,000 | -40.2% | 51,120 | -4.3% | 0.00% | -50.0% |
| Q4 2019 | $2,907,368,000 | -64.0% | 53,405 | -72.4% | 0.00% | -60.0% |
| Q3 2019 | $8,083,583,000 | +3.2% | 193,758 | +8.4% | 0.01% | -16.7% |
| Q2 2019 | $7,830,352,000 | +2101.0% | 178,816 | +2487.0% | 0.01% | – |
| Q1 2019 | $355,761,000 | +39.2% | 6,912 | 0.0% | 0.00% | – |
| Q4 2018 | $255,606,000 | +3.1% | 6,912 | +4.7% | 0.00% | – |
| Q3 2018 | $247,830,000 | – | 6,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 1,111,111 | $154,344,000 | 72.03% |
| Knoll Capital Management, LLC | 856,844 | $119,024,000 | 59.36% |
| ORACLE INVESTMENT MANAGEMENT INC | 2,124,055 | $295,053,000 | 36.73% |
| ARS Investment Partners, LLC | 466,668 | $64,825,000 | 6.49% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 365,373 | $50,754,000 | 6.18% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 176,400 | $24,490,000 | 5.91% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 61,897 | $8,598,000 | 4.86% |
| DAFNA Capital Management LLC | 88,100 | $12,238,000 | 3.25% |
| Avidity Partners Management LP | 934,200 | $129,770,000 | 2.88% |
| Eventide Asset Management | 1,325,000 | $184,056,000 | 2.43% |